Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
More news for Friday, Jan. 27
By
Kimberly Bonvissuto
Jan 27, 2023
Headwinds may stall CCRC recovery, Fitch Ratings says … Turnover rates among assisted living staff hold steady for most operators: report … FDA advisory committee votes on proposed COVID-19 vaccine...
Adenoviral-based COVID-19 vaccines may up short-term CV risk
Aug 23, 2022
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
UK is first country to approve Moderna omicron-targeted vaccine
Aug 15, 2022
The updated vaccine is expected to have a “important role” in protecting people from COVID-19 this winter.
Pollution tied to risk for serious COVID-19 despite vaccination
Oct 07, 2022
Exposures to PM2.5 and NO2 was linked to increased risk for COVID-19-related hospitalization, with and without adjustment for vaccination.
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
70 percent of COVID deaths are among those 75+, experts say, urging staying up to date on vaccination
By
Kimberly Bonvissuto
Oct 11, 2022
Despite many Americans being determined to “move on” from the pandemic and resume normal activities, COVID-19 continues to exact a toll, particularly among older adults, according to two new data analyses.
‘Unprecedented’ season sees vaccines for all three viruses affecting seniors
By
Kimberly Bonvissuto
Sep 26, 2023
The nation is entering an “unprecedented vaccine season,” with the availability of vaccines for three viruses responsible for the most hospitalizations among older adults, according to Omnicare pharmacists.
COVID-19 vaccination bests natural immunity for cutting death, hospitalizations
Dec 28, 2022
Natural immunity, however, was tied to a lower incidence of new infection.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.